189089-90-5 Usage
General Description
1-Benzenesulfonyl-1H-pyrrolo[2,3-b]pyridine-2-carboxylic acid is a chemical compound with the molecular formula C19H12N2O4S. It is a derivative of pyrrolopyridine and carboxylic acid. The compound contains a benzenesulfonyl group attached to the pyrrolopyridine ring, as well as a carboxylic acid group. This chemical is often used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of potential anti-cancer and anti-inflammatory drugs. Its molecular structure and functional groups make it a valuable building block for the synthesis of diverse organic compounds and pharmaceuticals.
Check Digit Verification of cas no
The CAS Registry Mumber 189089-90-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,9,0,8 and 9 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 189089-90:
(8*1)+(7*8)+(6*9)+(5*0)+(4*8)+(3*9)+(2*9)+(1*0)=195
195 % 10 = 5
So 189089-90-5 is a valid CAS Registry Number.
InChI:InChI=1/C14H10N2O4S/c17-14(18)12-9-10-5-4-8-15-13(10)16(12)21(19,20)11-6-2-1-3-7-11/h1-9H,(H,17,18)
189089-90-5Relevant articles and documents
Synthesis, biological evaluation and molecular modeling of a novel series of 7-azaindole based tri-heterocyclic compounds as potent CDK2/Cyclin E inhibitors
Baltus, Christine B.,Jorda, Radek,Marot, Christophe,Berka, Karel,Bazgier, Václav,Kry?tof, Vladimír,Prié, Gildas,Viaud-Massuard, Marie-Claude
, p. 701 - 719 (2016/01/09)
From four molecules, inspired by the structural features of fascaplysin, with an interesting potential to inhibit cyclin-dependent kinases (CDKs), we designed a new series of tri-heterocyclic derivatives based on 1H-pyrrolo[2,3-b]pyridine (7-azaindole) an
AZAINDOLE CARBOXAMIDES
-
Page/Page column 30, (2010/11/30)
The invention relates to azaindole derivatives of general formula (I), wherein X represents a group of general formula (X1). Said compounds have a therapeutic potential in the treatment of diseases that are accompanied by an impaired dopamine metabolism a
